Author:
Faris Jason E.,Arnott Jamie,Zheng Hui,Ryan David P.,Abrams Thomas A.,Blaszkowsky Lawrence S.,Clark Jeffrey W.,Enzinger Peter C.,Hezel Aram F.,Ng Kimmie,Wolpin Brian M.,Kwak Eunice L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference17 articles.
1. Cancer Facts and Figures (2010) American Cancer Society 2010
2. Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheet: Pancreas. Available at http://www.seer.cancer.gov/statfacts/html/pancreas.html (Accessed April 14, 2011)
3. Casper ES (1993) Pancreatic cancer: how can we progress? Eur J Cancer 29A(2):171–172
4. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413
5. Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd (2002) Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 20(15):3270–3275
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献